Video Experimental Relacionado
Updated: Jun 29, 2026
07:26
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Mapeo de un locus de susceptibilidad para la enfermedad de Crohn en el cromosoma 16
J P Hugot1, P Laurent-Puig, C Gower-Rousseau
1Laboratoire de Génétique des Tumeurs, INSERM U 434, Institut Curie, Paris France.
Nature
|February 29, 1996
Resumen
Los investigadores identificaron una ubicación genética específica en el cromosoma 16 relacionada con la susceptibilidad a la enfermedad de Crohn (EC). Este hallazgo avanza en la comprensión de los factores genéticos que contribuyen a esta enfermedad inflamatoria intestinal crónica.
Área de la Ciencia:
- Genética La genética.
- Gastroenterología y Gastroenterología.
- Epidemiología La epidemiología.
Sus antecedentes:
- Las enfermedades inflamatorias intestinales, incluida la enfermedad de Crohn (EC) y la colitis ulcerosa, son enfermedades crónicas prevalentes que afectan a los adultos jóvenes.
- Se desconocen las causas exactas de estas enfermedades, pero se sospecha que los factores genéticos influyen en la susceptibilidad individual a la CD.
Objetivo del estudio:
- Para identificar los loci genéticos asociados con la susceptibilidad a la enfermedad de Crohn.
- Investigar el papel de los factores hereditarios en el desarrollo de la CD.
Principales métodos:
- Se realizó una búsqueda de todo el genoma utilizando un análisis no paramétrico de vinculación de pares de hermanos de dos puntos.
- Se utilizaron dos paneles familiares independientes con múltiples miembros afectados.
- Se empleó el análisis de pares de hermanos multipunto para refinar la localización del locus.
Principales resultados:
- Se identificó un locus de susceptibilidad significativo para la enfermedad de Crohn en el cromosoma 16 (P <0,01 en ambos paneles).
- Análisis adicionales localizaron esta región en los loci D16S409 y D16S419 (P < 1.5x10(-5)).
- Esta región cromosómica contiene genes candidatos potenciales implicados en la patogénesis de la enfermedad inflamatoria intestinal.
Conclusiones:
- Un nuevo locus genético en el cromosoma 16 se asocia con la enfermedad de Crohn.
- Este descubrimiento proporciona una base para futuras investigaciones sobre los genes específicos y los mecanismos patógenos subyacentes a CD.
- Comprender estas contribuciones genéticas es crucial para desentrañar la etiología de las enfermedades inflamatorias intestinales.
Videos de Conceptos Relacionados
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...